Hamilton Beach Brands Company (HBB) Q1 2025 earnings summary

Executive summary

• Revenue increased 4.0% year-over-year to $133.4 million for Q1 2025, driven by favorable product mix, higher volume, and strong U.S. consumer demand, partially offset by pricing and foreign currency impacts.

• Gross margin rose to 24.6% from 23.4% year-over-year, aided by higher-margin HealthBeacon business and product mix.

• Operating profit reached $2.3 million, reversing a prior year loss of $0.9 million.

• Net income was $1.8 million ($0.13 per diluted share), compared to a net loss of $1.2 million ($0.08 per share) last year.

• Strategic initiatives included core growth, premium market share, commercial expansion, health segment growth, digital transformation, and partnerships.

Financial highlights

• Gross profit increased to $32.8 million (24.6% margin) from $30.1 million (23.4%) in Q1 2024.

• SG&A expenses decreased, mainly due to non-recurring HealthBeacon acquisition costs in the prior year.

• Net cash from operating activities was $6.6 million, down from $19.7 million, reflecting lower trade receivable collections and inventory build ahead of tariff uncertainty.

• Share repurchases totaled up to 180,556 shares for $3.4 million; $1.6 million paid in dividends.

• Net debt reduced to $1.7 million from $23.7 million year-over-year.

Outlook and guidance

• Guidance is temporarily suspended due to unpredictability from recent U.S. tariff escalations and trade negotiations.

• Margin benefits from sourcing diversification are expected to materialize in 2026.

• Management expects revenue to increase in the second half of the year, peaking in Q4 due to seasonal demand.